Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bonsai Partners is Betting on Illumina (ILMN) Stock

Bonsai Partners recently released its Q2 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 101.8% for the quarter (net of fees), outperforming their benchmark, the S&P 500 Index which returned 20.5% in the same quarter. You should check out Bonsai Partners’ top 5 stock picks for investors to buy right now, which could be the biggest winners of the stock market crash.

In the said letter, Bonsai Partners highlighted a few stocks and Illumina Inc. (NASDAQ:ILMN) is one of them. Illumina Inc. (NASDAQ:ILMN) is a biotechnology company. Year-to-date, Illumina Inc. (NASDAQ:ILMN) stock gained 6.6% and on August 17th it had a closing price of $354.13. Bonsai Partners cared to mention Illumina Inc. (NASDAQ:ILMN) in its investor letter, though they didn’t say why they really like the stock. All they said is this:

“Illumina is the leading provider of genomic sequencing instruments and reagents.

Illumina appreciated 34% during the quarter.

Despite an unusual operating environment, the quarter was reasonably quiet for Illumina. The company continues to be a vital part of the Life Sciences research industry, and despite temporary disruptions experienced by lab customers this past quarter, Illumina’s technology continues to be a key enabler of progress in the field.”

15 Biggest US Government Cover Ups of All Time

Tonhom1009/Shutterstock.com

In Q1 2020, the number of bullish hedge fund positions on Illumina Inc. (NASDAQ:ILMN) stock decreased by about 21% from the previous quarter (see the chart here), so a number of other hedge fund managers don’t seem to agree with Illumina’s growth potential. Our calculations showed that Illumina Inc. (NASDAQ:ILMN) isn’t ranked among the 30 most popular stocks among hedge funds.

The top 10 stocks among hedge funds returned 185% since the end of 2014 and outperformed the S&P 500 Index ETFs by more than 109 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Below you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we scour multiple sources to uncover the next great investment idea. Cannabis stocks are roaring back in 2020, so we are checking out this under-the-radar stock. We go through lists like the 10 most profitable companies in America to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. If you want to find out the best healthcare stock to buy right now, you can watch our latest hedge fund manager interview here. You can subscribe to our free enewsletter below to receive our stories in your inbox:

Disclosure: None. This article is originally published at Insider Monkey.